Cubist Systematic Strategies, LLC - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 232 filers reported holding GENMAB A/S in Q4 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of GENMAB A/S
ValueSharesWeighting
Q3 2023$1,084,447
-67.8%
30,747
-65.3%
0.01%
-63.6%
Q2 2023$3,370,537
+1357.1%
88,675
+1347.5%
0.02%
+2100.0%
Q1 2023$231,318
-97.7%
6,126
-97.4%
0.00%
-98.3%
Q4 2022$9,906,367
+106.9%
233,751
+56.9%
0.06%
+114.8%
Q3 2022$4,788,000
+138.2%
149,010
+140.9%
0.03%
+125.0%
Q2 2022$2,010,000
-29.9%
61,857
-21.9%
0.01%
-50.0%
Q1 2022$2,866,000
+40.9%
79,211
+54.0%
0.02%
+26.3%
Q4 2021$2,034,000
-25.7%
51,427
-17.9%
0.02%
-44.1%
Q3 2021$2,736,000
-39.8%
62,620
-43.8%
0.03%
-33.3%
Q2 2021$4,547,000
+479.2%
111,359
+365.9%
0.05%
+410.0%
Q1 2021$785,000
+97.2%
23,901
+144.0%
0.01%
+100.0%
Q4 2020$398,000
-62.1%
9,797
-65.8%
0.01%
-68.8%
Q3 2020$1,050,000
-70.7%
28,677
-72.9%
0.02%
-74.2%
Q2 2020$3,584,000
+848.1%
105,756
+493.3%
0.06%
+520.0%
Q1 2020$378,000
-29.6%
17,825
-25.9%
0.01%0.0%
Q4 2019$537,00024,0580.01%
Other shareholders
GENMAB A/S shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 242,848$9,169,9403.80%
Capricorn Fund Managers Ltd 110,643$4,177,8801.28%
Arlington Capital Management, Inc. 35,591$1,343,9161.26%
XY Capital Ltd 76,884$2,903,1401.13%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 88,000$3,322,8800.93%
TORRAY INVESTMENT PARTNERS LLC 110,807$4,184,0720.75%
Hardman Johnston Global Advisors LLC 585,139$22,094,8490.72%
Yorktown Management & Research Co Inc 16,600$626,8160.68%
First Light Asset Management, LLC 160,025$6,042,5440.54%
MIRABELLA FINANCIAL SERVICES LLP 28,260$2,505,8550.38%
View complete list of GENMAB A/S shareholders